Literature DB >> 12593670

Negative regulation of gp130 signalling mediated through tyrosine-757 is not dependent on the recruitment of SHP2.

W Douglas Fairlie1, David De Souza, Nicos A Nicola, Manuel Baca.   

Abstract

Cytokines of the interleukin-6 family utilize the shared cytokine receptor gp130 in the formation of active signalling complexes. Tyrosine-757 (Y757) on this receptor is critical for negative regulation of gp130-mediated signalling. Two signalling regulators, suppressor of cytokine signalling 3 (SOCS3) and Src homology 2 domain-containing tyrosine phosphatase-2 (SHP2), are recruited to Y757 following receptor activation; however, the relative contribution made by each of these in down-regulating gp130 signalling is not known. In the present study, we show the design of a mutant gp130 receptor that can recruit SHP2, but not SOCS3. This receptor maintains the critical Y757 residue, but contains mutations in other surrounding residues which are also important for interactions with the Src homology 2 domains of SOCS3 and SHP2. Cells transfected with a chimaeric receptor containing the SHP2-selective gp130 intracellular domain showed an enhanced response to cytokine stimulation, which was similar to that shown by a chimaeric gp130 receptor mutant carrying a Y757F point mutation that failed to recruit either SOCS3 or SHP2. These results demonstrate that the recruitment of SHP2 alone is not sufficient for Y757-dependent negative regulation of gp130 signalling and that this activity must therefore be dependent on SOCS3.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12593670      PMCID: PMC1223392          DOI: 10.1042/BJ20030104

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  A new protein containing an SH2 domain that inhibits JAK kinases.

Authors:  T A Endo; M Masuhara; M Yokouchi; R Suzuki; H Sakamoto; K Mitsui; A Matsumoto; S Tanimura; M Ohtsubo; H Misawa; T Miyazaki; N Leonor; T Taniguchi; T Fujita; Y Kanakura; S Komiya; A Yoshimura
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

2.  Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis.

Authors:  T Fukada; M Hibi; Y Yamanaka; M Takahashi-Tezuka; Y Fujitani; T Yamaguchi; K Nakajima; T Hirano
Journal:  Immunity       Date:  1996-11       Impact factor: 31.745

3.  Crystal structure of the tyrosine phosphatase SHP-2.

Authors:  P Hof; S Pluskey; S Dhe-Paganon; M J Eck; S E Shoelson
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

4.  Modification of a PCR-based site-directed mutagenesis method.

Authors:  C L Fisher; G K Pei
Journal:  Biotechniques       Date:  1997-10       Impact factor: 1.993

5.  A family of cytokine-inducible inhibitors of signalling.

Authors:  R Starr; T A Willson; E M Viney; L J Murray; J R Rayner; B J Jenkins; T J Gonda; W S Alexander; D Metcalf; N A Nicola; D J Hilton
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

6.  Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2.

Authors:  T M Saxton; M Henkemeyer; S Gasca; R Shen; D J Rossi; F Shalaby; G S Feng; T Pawson
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

7.  Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells.

Authors:  H Kim; T S Hawley; R G Hawley; H Baumann
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

Review 8.  Gp130 and the interleukin-6 family of cytokines.

Authors:  T Taga; T Kishimoto
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

9.  The protein tyrosine phosphatase SHP-2 negatively regulates ciliary neurotrophic factor induction of gene expression.

Authors:  A Symes; N Stahl; S A Reeves; T Farruggella; T Servidei; T Gearan; G Yancopoulos; J S Fink
Journal:  Curr Biol       Date:  1997-09-01       Impact factor: 10.834

10.  Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis.

Authors:  T Tauchi; J E Damen; K Toyama; G S Feng; H E Broxmeyer; G Krystal
Journal:  Blood       Date:  1996-06-01       Impact factor: 22.113

View more
  9 in total

1.  Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Tatiana M Fontelonga; Brennan Jordan; Andreia M Nunes; Pamela Barraza-Flores; Nicholas Bolden; Ryan D Wuebbles; Lesley Mathews Griner; Xin Hu; Marc Ferrer; Juan Marugan; Noel Southall; Dean J Burkin
Journal:  Hum Mol Genet       Date:  2019-07-01       Impact factor: 6.150

Review 2.  The molecular details of cytokine signaling via the JAK/STAT pathway.

Authors:  Rhiannon Morris; Nadia J Kershaw; Jeffrey J Babon
Journal:  Protein Sci       Date:  2018-12       Impact factor: 6.725

Review 3.  Inhibition of IL-6 family cytokines by SOCS3.

Authors:  Jeffrey J Babon; Leila N Varghese; Nicos A Nicola
Journal:  Semin Immunol       Date:  2014-01-10       Impact factor: 11.130

4.  SOCS2 negatively regulates growth hormone action in vitro and in vivo.

Authors:  Christopher J Greenhalgh; Elizabeth Rico-Bautista; Mattias Lorentzon; Anne L Thaus; Phillip O Morgan; Tracy A Willson; Panagiota Zervoudakis; Donald Metcalf; Ian Street; Nicos A Nicola; Andrew D Nash; Louis J Fabri; Gunnar Norstedt; Claes Ohlsson; Amilcar Flores-Morales; Warren S Alexander; Douglas J Hilton
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

5.  Leptin signaling: A key pathway in immune responses.

Authors:  Claudio Procaccini; Elaine V Lourenco; Giuseppe Matarese; Antonio La Cava
Journal:  Curr Signal Transduct Ther       Date:  2009-01-01

Review 6.  The biology and mechanism of action of suppressor of cytokine signaling 3.

Authors:  Jeffrey J Babon; Nicos A Nicola
Journal:  Growth Factors       Date:  2012-05-11       Impact factor: 2.511

Review 7.  Intracellular signalling pathways activated by leptin.

Authors:  Gema Frühbeck
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

Review 8.  SHP-2 in Lymphocytes' Cytokine and Inhibitory Receptor Signaling.

Authors:  Charlène Niogret; Walter Birchmeier; Greta Guarda
Journal:  Front Immunol       Date:  2019-10-25       Impact factor: 7.561

Review 9.  IL-6 in inflammation, autoimmunity and cancer.

Authors:  Toshio Hirano
Journal:  Int Immunol       Date:  2021-03-01       Impact factor: 4.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.